Skip to content

*Fragrance allergy and skin tolerability to essential oils*

*Fragrance allergy and skin tolerability to essential oils* - 'Fragrance study'

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32295
Enrollment
100
Registered
2008-06-04
Start date
2008-07-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic contact dermatitis to fragrances

Interventions

All participants are offered patch tests, a skin irritability test and a repeated open application test (user test) with (components of) cosmetics.

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed contact allergy to fragrance (mix I and/or II) with a positive patch test (+, ++ or +++ interpreted according to the ICDRG guidelines) Clinical healthy skin of the back in two preceding weeks Written informed consent

Exclusion criteria

Exclusion criteria: Pregnancy or lactation Age under 18 or above 70 Legally incompetent adults Topical treatment of immunosuppressives on the back and arms within 7 days before performing patch tests and until finalization Commercial skin lotions and ointments on the back and arms less than 8 hours before patch testing Extensive UV exposure of the back and arms in the last 14 days before performing patch tests and until finalization Usage of systemic immunosuppressive drugs (e.g. prednison, acitretine, adalimumab, efalizumab, etanercept, methoxsaleen, cyclosporine, azathioprine, infliximab and methothrexate) NB: Medication that reasonably not intervenes with the study procedures (e.g. an antihistaminicum can be used during the study) Severe illness, defined as life threatening or severely disabling

Design outcomes

Primary

MeasureTime frame
The primary study parameters are reactions regarding the ICDRG guidelines on patchtests, skin irritability tests and a repeated open application test (user test).

Secondary

MeasureTime frame
not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)